coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Widnes PCN, Halton (LAD) · Health Inequalities Profile

    PCN U79408 · NHS Cheshire and Merseyside Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    67,701

    Registered population

    60.2% aged 18–64

    20.2%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.4%

    Ethnic minority (non-White)

    1.2% Asian · England 9.6%

    40.4%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~27,385

    Core20 residents (est.)

    Resident basis; registered basis ~28,154 · see page 3

    12,050

    Hypertension register

    +8.08% in 3 yrs · England +5.60%

    626

    SMI register

    47.9% of Halton (LAD)'s

    1,901

    COPD register

    Reviews +8.38% in 3 yrs

    Forecast to 2030

    14,246

    Hypertension patients, 2030

    +2,196 on today

    62.8%

    QRISK ≥20% on statins, 2030

    +1.01pp over 3 yrs

    5.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    80.6%
    COPD and hypertension care exceed national benchmarks.

    Annual COPD reviews reach 80.6% (England 76.4%, growing +8.4% vs +2.8%), while hypertension treatment to target reaches 72.3% (England 70.3%, +7.3% vs +3.6%).

    60.8%
    Lipid therapy and non-frail diabetes control lag.

    QRISK ≥ 20% lipid therapy is 60.8% (England 63.6%, growing +1.7% vs +6.2%) and non-frail diabetes HbA1c control is 50.7% (England 57.4%).

    1,800
    Asthma review backlog and falling dementia register.

    Asthma reviews at 62.8% (England 65.7%) leave about 1,800 of 4,843 patients unreviewed, while dementia prevalence fell 3.6% (England +6.0%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 20.2% of the list, above England's 17.9% average

    WIDNES PCN registers 67,701 patients across member practices. Patients aged 65+ make up 20.2% of the list (13,652 patients), higher than Halton (LAD) (17.5%), the ICB (19.0%), and England (17.9%). Those aged 18 to 64 represent 60.2% (40,760 patients), below Halton (LAD) (62.4%), the ICB (61.9%), and England (62.7%), while children aged 0 to 17 form 19.6% (13,289 patients; Halton (LAD) 20.0%, ICB 19.2%, England 19.6%). Census usual-resident estimates indicate 96.6% are White (Halton (LAD) 96.5%, ICB 93.0%, England 81.1%), with a 3.4% non-White ethnic minority share.

    Age profile

    0–1719.6%
    18–6460.2%
    65+20.2%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.6%
    Mixed1.3%
    Asian1.2%
    Other0.5%
    Black0.3%

    Older people · falls rows are Halton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Halton LA)2,1942,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)50.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Halton LA)1,1201,0219552024/25
    Falls deaths, all ages, per 100,000 (Halton LA)21.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 40.4% across the PCN with a 70.0 pp practice range

    Across WIDNES PCN, 40.4% of registered patients live in Core20 areas, below Halton (LAD) (44.7%) but above NHS Cheshire and Merseyside Integrated Care Board (31.9%) and England (21.0%). Modelled weighted practice share is 41.6% (a 1.22 percentage point divergence). Practice shares span a 70.0 pp range, from 6.2% at Upton Rocks Primary Care to 76.3% at Oaks Place Surgery. Oaks Place Surgery has the highest share, while Peelhouse Medical Plaza has the largest estimated volume (5,549). Targeting must balance high-concentration outreach with high-volume clinical capacity.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Oaks Place76.3% · 2,981 patients
    Hough Green67.7% · 3,543 patients
    Newtown60.3% · 4,005 patients
    Beeches Medical57.1% · 4,670 patients
    Peelhouse Medical40.5% · 5,549 patients
    Bevan28.2% · 4,028 patients
    Fir Park25.9% · 3,155 patients
    Upton Rocks6.2% · 223 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    626

    SMI register

    0.92% recorded prevalence

    452

    Learning disability register

    0.66% recorded prevalence

    16

    Care homes, 454 beds

    In the PCN catchment

    11.3%

    Provide unpaid care

    Halton (LAD), Census 2021

    Recorded prevalence is 0.7% for learning disability (452 patients; England 0.6%) and 0.9% for severe mental illness (626 patients; England 1.0%), with 454 beds across 16 catchment care homes. Separate Halton borough data shows an 11.3% unpaid care rate and 6 rough sleepers in autumn 2025.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reach 84.7% (England 83.4%) and BMI recording reaches 82.5% (England 82.1%). Over 2023 to 2025, blood pressure check growth of +3.4 pp trailed England (+4.4 pp). Routine physical monitoring remains a local priority.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,050

    Hypertension register

    +8.08%

    Register growth, 3 yrs

    Halton (LAD) +6.68% · England +5.60%

    +4.58pp

    BP control, under 80

    ≤140/90 · +4.03pp aged 80+

    +2,196

    More patients by 2030

    Forecast 14,246 (20.63%)

    Hypertension case-finding and control

    Hypertension QOF prevalence is 17.7% (12,050 patients), matching Halton (LAD) at 17.7% and above the ICB (16.8%) and England (15.2%). While treatment to target reaches 72.3% (England 70.3%, Halton 71.2%), the share with a recent blood pressure reading is 88.7% (England 90.0%, Halton 88.9%), and three-year recording growth (+2.3% over 2023 to 2025) lagged England (+3.6%). Crude prevalence does not establish undiagnosed disease, but varied across practices from 10.9% at Oaks Place Surgery to 19.6% at The Beeches Medical Ctr. Strong blood pressure control among monitored patients highlights an opportunity to expand routine annual checks across practices.

    Lipids and statins

    Lipid therapy for patients with QRISK ≥ 20% reaches 60.8%, trailing Halton (LAD) at 62.5%, the ICB at 63.2%, and England at 63.6%, with three-year growth (+1.7% over 2023 to 2025) behind England (+6.2%). Lower uptake compared to regional and national benchmarks could reflect unverified variation in primary-prevention prescribing.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026126,917£1.90£1.71£1.86£241,142
    Cardiovascular (all), 2025194,565£4.68£4.37£3.33£910,564

    In 2026, lipid-modifying drugs cost £1.90 per item across 126,917 items (£241,142 spend), compared with £1.87 in Halton (LAD), £1.86 in England, and £1.71 in the ICB; the PCN spends £5,077 more than at England's unit cost. This difference reflects unit cost rather than prescribing efficiency, case-mix, or formulary adherence.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.89%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.54%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.8% (1,901 patients), with reviews at 80.6% (England 76.4%), up +8.4% over 2023 to 2025 (England +2.8%). Conversely, asthma reviews reach 62.8% (England 65.7%), trailing England's 3-year growth (+2.9% vs +4.4%) and leaving about 1,800 patients unreviewed across the 4,843 register. For asthma patients aged 6-19, second-hand smoke recording is 75.0% (England 78.8%) alongside 2,284 items prescribed per 1,000 aged 5-19 (England 1,488). Focusing recall on paediatric asthma reviews could help address this unverified care gap.

    Cancer register and children's immunisation

    Cancer: QOF prevalence (all ages) is 4.5% at PCN level, above Halton (LAD) (4.4%), above NHS Cheshire and Merseyside Integrated Care Board (4.3%) and above England (3.8%). Crude prevalence does not establish unmet need or under-detection, but may reflect local demographic need or diagnostic recording.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.1%

    England 91.0%

    6-in-1 complete primary course at 24 months94.9%

    England 92.2%

    MMR dose 1 at 24 months92.6%

    England 88.3%

    MMR dose 2 at age 583.4%

    England 82.8%

    4-in-1 pre-school booster at age 582.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, NHS Cheshire and Merseyside ICB diagnosed 55.5% of staged cancers at stage 1 or 2 (7,482 of 13,490 cases; England 55.3%), 19.5 pp below the 75.0% national ambition, requiring about 2,640 extra early-stage diagnoses. Known-stage coverage was 72.8% (13,490 of 18,522 cases; England 67.0%). Early diagnosis was 44.9% for bowel (England 47.0%) and 40.4% for lung (England 33.8%). PCN breast screening was 73.9% (England 69.9%) and cervical screening was 70.4% (England 66.8%). However, cervical screening lagged at Newtown Surgery (59.3%), Hough Green Health Park (64.9%), and The Beeches Medical Ctr (65.5%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Mersey and West Lancashire Teaching Hospitals NHS Trust, 62-day referral to treatment was 77.96% (7.0 pp below the 85.0% standard), while NHS Cheshire and Merseyside ICB reached 76.23%. For the 28-day faster diagnosis standard, the trust achieved 72.39% (2.6 pp below the 75.0% standard), whereas the ICB reached 77.25%. The 31-day combined treatment standard was 95.46% at the trust and 95.71% across the ICB against the 96.0% standard. These wider-system operational metrics reflect trust and ICB delivery rather than PCN performance, and local referral pathways have not been verified.

    Pathways within standard (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)72.3980.2175.4777.2579.32
    31-day treatment (96%)95.4698.1790.5195.7192.50
    62-day referral to treatment (85%)77.9683.6773.2676.2371.16
    Diagnostic waits over 6 weeks (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolEngland
    MRI14.040.536.4221.40
    CT13.082.320.719.92
    Echocardiography34.8828.0412.5528.48
    Colonoscopy18.0415.9833.1430.83
    Gastroscopy18.1720.2444.9929.02
    All 15 DM01 tests21.176.3411.5023.14
    Community services activityHalton residentsCheshire and Merseyside ICB
    Care contacts19,830541,280
    Referrals3,18597,150
    Patients with a contact6,225146,240

    Community services (residents of Halton), Jun 2026 (provisional). Provisional June 2026 Community Services Dataset records show that Halton borough residents accounted for 19,830 community contacts, of which 11,325 contacts (57.1%) were with adults aged 65 and over. These figures describe wider borough activity among residents rather than PCN registered patients, and do not represent PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access and immunisation achievement vary sharply across member practices

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Upton Rocks1126.261.0%75.0%76.5%
    Bevan12028.228.1%77.3%74.7%
    Beeches Medical11057.151.0%63.8%73.9%
    Hough Green11767.764.5%72.2%72.9%
    Oaks Place Surgery13276.372.5%60.5%71.7%
    Fir Park9825.942.8%75.5%71.3%
    Peelhouse Medical11940.529.3%80.2%67.2%
    Newtown Surgery11860.344.4%76.4%64.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHalton (LAD)AssetPCNHalton (LAD)
    Care homes (catchment)16 (454 beds)n/aSchools (catchment)64n/a
    Children's centres48Places of worship3055
    Libraries12Primary schools (LA maintained)1533
    Primary academies513Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Asthma reviews reach 62.8% vs 65.7% in England and 63.4% in Halton (LAD), with 2023 to 2025 growth (+2.9%) trailing England (+4.4%); about 1,800 of 4,843 register patients lack a recorded review. For discussion: practices could run a single-template asthma recall offering flexible after-school slots and checking second-hand smoke recording. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Dementia register and coding audit

    Dementia register prevalence is 0.8% (553 patients, matching England's 0.8%), but fell 3.6% over 2023 to 2025 while Halton (LAD) grew +2.2%, the ICB +6.2%, and England +6.0%. For discussion: practices could audit clinical records for uncoded memory clinic letters or cognitive assessments and review care-home register coding. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 3

    Targeted COPD case-finding search

    COPD prevalence is 2.8% (1,901 patients across 67,701 registered), above England (1.9%) and the ICB (2.5%) but below Halton (LAD) (3.2%), giving a benchmark gap range of -618 to +239 patients. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult service alignment (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Dual-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check recall (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension monitoring recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Primary care phone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Dementia register and coding audit (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 3 · Targeted COPD case-finding search (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15